Search by Drug Name or NDC

NDC 42291-0781-42 Sucralfate 1 g/10mL Details

Sucralfate 1 g/10mL

Sucralfate is a ORAL SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvKARE. The primary component is SUCRALFATE.

MedlinePlus Drug Summary

Sucralfate is used to treat and prevent the return of duodenal ulcers (ulcers located in first part of the small intestine). Treatment with other medications, such as antibiotics, may also be necessary to treat and prevent the return of ulcers caused by a certain type of bacteria (H. pylori) Sucralfate is in a class of medications called protectants. It sticks to damaged ulcer tissue and protects against acid and enzymes so healing can occur.

Related Packages: 42291-0781-42
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Sucralfate

Product Information

NDC	42291-0781
Product ID	42291-781_0e9ac01f-7d10-e0c3-e063-6294a90aa5c7
Associated GPIs	49300010001820
GCN Sequence Number	016133
GCN Sequence Number Description	sucralfate ORAL SUSP 1 G/10 ML ORAL
HIC3	D4E
HIC3 Description	ANTI-ULCER PREPARATIONS
GCN	07651
HICL Sequence Number	001186
HICL Sequence Number Description	SUCRALFATE
Brand/Generic	Generic
Proprietary Name	Sucralfate
Proprietary Name Suffix	n/a
Non-Proprietary Name	Sucralfate Oral
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	SUSPENSION
Route	ORAL
Active Ingredient Strength	1
Active Ingredient Units	g/10mL
Substance Name	SUCRALFATE
Labeler Name	AvKARE
Pharmaceutical Class	Aluminum Complex [EPC], Organometallic Compounds [CS]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA209356
Listing Certified Through	2025-12-31

Package

NDC 42291-0781-42 (42291078142)

Pricing Information	N/A
NDC Package Code	42291-781-42
Billing NDC	42291078142
Package	420 mL in 1 BOTTLE (42291-781-42)
Marketing Start Date	2021-04-16
NDC Exclude Flag	N